Walker v. Pharmaceutical Research and Mfrs.

Decision Date07 August 2008
Docket NumberCivil Action No. 04-1991 (RMU).
Citation569 F.Supp.2d 209
PartiesBarbara J. WALKER, Plaintiff, v. PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA et al., Defendants.
CourtU.S. District Court — District of Columbia

Barbara J. Walker, Alexandria, VA, pro se.

Frederick G. Sandstrom, Jeffrey G. Huvelle, Covington & Burling, LLP, Christopher A. Weals, Morgan, Lewis & Bockius, Washington, DC, for Defendants.

MEMORANDUM OPINION

GRANTING IN PART AND DENYING IN PART THE INDIVIDUAL DEFENDANTS' MOTION TO DISMISS; GRANTING IN PART AND DENYING IN PART THE NEW YORK LIFE DEFENDANTS' MOTION FOR SUMMARY JUDGMENT

RICARDO M. URBINA, District Judge.

I. INTRODUCTION

The remaining defendants in this lengthy litigious saga set before this court a motion to dismiss and a motion for summary judgment. Individuals who are current or former members of the board of directors of Pharmaceutical Research and Manufacturers of America1 ("PhRMA") and members of the PhRMA retirement committee (collectively the "individual defendants") filed the motion to dismiss. New York Life Insurance Company ("NYLIC") and New York Life Investment Management, Inc. ("NYLIM") (collectively the "New York Life defendants") filed the motion for summary judgment. Both groups of defendants raise numerous arguments against the plaintiff's claims, which stem from alleged violations of the Employee Retirement Income Security Act of 1974 ("ERISA"), 29 U.S.C. §§ 1001 et seq. Because the plaintiff failed to properly serve 10 of the individual defendants, the court allows 30 days for the plaintiff, proceeding pro se, to properly effect service. Furthermore, because claims arising before November 15, 1998 are definitively time barred, and because the plaintiff may not re-hash old legal arguments to bring back claims that this court previously dismissed, the court dismisses many of the plaintiff's ERISA claims. But, the court does not dismiss the plaintiffs claims that allege that the remaining defendants failed to respond to requests for, or disclose, ERISA plan documents in more recent years.

II. BACKGROUND
A. Factual Background

The plaintiff, an attorney, was a fulltime employee of PhRMA in various professional capacities from 1977 to 1988. Mem. Op. (July 17, 2006), 439 F.Supp.2d 103, 105. Following the birth of her second child in 1988, the plaintiff requested but was denied a part-time work arrangement because PhRMA's then-president "did not believe in part-time professionals." Id. Instead, PhRMA's General Counsel, Bruce Brennan, suggested that the plaintiff serve as an independent contractor. Id. The plaintiff accepted this arrangement and signed an independent contractor agreement on March 24, 1988.2 Id. At the expiration of that agreement, the plaintiff and PhRMA signed identically worded agreements every year until 2001. Id. at 105-06. The final agreement, signed on September 12, 2001, notified the plaintiff that PhRMA did not intend to continue their relationship following the expiration of the agreement on June 30, 2002. Id.

The independent contractor agreements signed by the plaintiff each year stated that the plaintiff "shall be engaged as an independent contractor, not as an employee, and shall not be entitled to participate in any of [PhRMA's] employee benefit plans." Id. at 105. The plaintiff alleges that she signed the independent contractor agreements based on the belief that parttime employees, like independent contractors, were ineligible for employee benefits. Id. at 105. In other words, the plaintiff alleges that she "had no reason" to challenge her classification as an independent contractor rather than as a part-time employee because she believed the "terms and conditions of her employment" were the same as those of part-time employees. Pls.' Mot. to Alter or Amend J. at 5.

Sometime between 1991 and 1994, PhRMA reinterpreted its retirement plan to make part-time employees eligible for certain retirement benefits. Id. at 5. The plaintiff alleges that the defendants violated ERISA because they failed to notify independent contractors of the changes affecting part-time employees. Id. at 5, 13, 16.

B. Procedural Background

The plaintiff filed her original complaint on November 11, 2004, and she amended her complaint in August 2005. Although difficult to parse, the complaint appears to assert the following claims arising under ERISA3: (1) that the plaintiff is entitled to benefits under 29 U.S.C. § 1132(a)(1)(B) ("ERISA § 502"); (2) that the defendants interfered with her rights to retirement benefits by improperly classifying her as an independent contractor, in violation of 29 U.S.C. § 1140 ("ERISA § 510"); and (3) that the defendants breached their fiduciary duties by either failing to notify the plaintiff that part-time employees were eligible to receive benefits, or by classifying her as an independent contractor, rather than as a part-time employee, in violation of 29 U.S.C. § 1104 ("ERISA § 404").

The PhRMA defendants4 moved for summary judgment in October 2005 on the grounds that the statute of limitations bars the plaintiffs ERISA claims and that ERISA preempts the plaintiff's common law claims. See generally PhRMA's Mot. In granting the PhRMA defendants' motion on July 17, 2006, the court determined that (1) the three-year statute of limitations bars the plaintiff's § 502 claim because it began to run when the parties executed an independent contractor agreement in 1988; (2) applying either a one-year or a three-year statute of limitation would bar the plaintiffs § 510 claim because the claim accrued in 1988, the year she learned that she was no longer eligible to participate in the PhRMA retirement plans; (3) the statute of limitations bars the plaintiffs § 404 claim because the plaintiff had knowledge of the alleged breach or violation more than three years before she filed suit; and (4) ERISA preempts the plaintiff's D.C. common law claims. See generally Mem. Op. (July 16, 2006).

The plaintiff then filed a motion to alter or amend judgment on July 31, 2006. The court denied the plaintiffs motion, reaffirming the dismissal of each of the plaintiffs claims. The court explained that the plaintiffs § 502 claim accrued the date of the clear repudiation of benefits, not, as the plaintiff argued in her motion, the date the defendants denied the plaintiffs claim for benefits. Mem. Op. (Nov. 15, 2006), 461 F.Supp.2d 52, 56-57. The court then rejected the plaintiffs argument that her waiver of benefits could not have been clear without the knowledge that part-time employees were entitled to benefits. Id. at 57. In rejecting this argument, the court reasoned that the repudiation of benefits is the communication at issue, not communications regarding other employees' benefits. Id. The court was similarly unmoved by the plaintiffs contention that the statute of limitations should be tolled because of the PhRMA defendants' alleged fraudulent concealment of part-time employees' eligibility for benefits. Id. at 57-58. First, the plaintiff was not a part-time employee. Id. Second, the PhRMA defendants' employee handbook, which the plaintiff was allegedly responsible for drafting, states that the 401(k) Deferred Savings Plan is offered to "all employees who are regularly scheduled to work at least 20 hours per week." Id. Third, in 1991, the plaintiff was aware of the "smoking gun" letter, which indicated to her that part-time workers were eligible for benefits. Id. at 59. Therefore, even if this knowledge is relevant to the plaintiffs claims, she would have been aware that part-time employees were entitled to at least some retirement benefits far earlier than the limitations period allows. Id. at 57-58. Finally, the court reiterated its conclusion that the plaintiff had actual knowledge of the PhRMA defendants' alleged breach of fiduciary duties5 more than three years before she filed her suit, which bars her § 404 claim.6 Id. at 59-60.

The individual defendants and the New York Life defendants have since filed motions to dismiss and for summary judgment respectively. The plaintiffs complaint alleges the same claims against these defendants as she alleged against the PhRMA defendants. Fully briefed, the court now turns to the defendants' motions.

III. ANALYSIS
A. The Plaintiff Failed to Properly Serve 10 Individual Defendants
1. Legal Standard for a Rule 12(b)(5) Motion to Dismiss

A party can move the court to dismiss a complaint under Federal Rule of Civil Procedure 12(b)(5) for insufficient service of process. "[T]he party on whose behalf service is made has the burden of establishing its validity when challenged; to do so, he must demonstrate that the procedure employed satisfied the requirements of the relevant portions of Rule 4 and any other applicable provision of law." Light v. Wolf, 816 F.2d 746, 751 (D.C.Cir. 1987) (internal quotations omitted); Hilska v. Jones, 217 F.R.D. 16, 20 (D.D.C.2003). Unless the procedural requirements of effective service of process are satisfied, a court lacks power to assert personal jurisdiction over a defendant. Gorman v. Ameritrade Holding Corp., 293 F.3d 506, 514 (D.C.Cir.2002) (citing Omni Capital Int'l, Ltd. v. Rudolf Wolff & Co., 484 U.S. 97, 104, 108 S.Ct. 404, 98 L.Ed.2d 415 (1987)).

2. The Court Allows Additional Time for the Plaintiff to Properly Serve the Individual Defendants

The plaintiff's amended complaint7 identifies 57 distinct8 individual defendants, consisting of past and present members of the board of directors of PhRMA and members of the retirement committee of PhRMA. Am. Compl. The individual defendants contend that 10 of the 57 individual defendants did not waive service and were not properly served.9 Ind. Defs.' Mot. at 8. The plaintiff protests that she properly served 5 of the 10 individual defendants in question. Pl.'s Opp'n to Ind. Defs.' Mot. ("Pl.'s Ind. Opp'n") at 1. Specifically, she contends that she served the individual...

To continue reading

Request your trial
8 cases
  • Walker v. Pharm. Research & Manufacturers of America
    • United States
    • U.S. District Court — District of Columbia
    • December 8, 2011
  • Marcin v. Reliance Standard Life Ins. Co.
    • United States
    • U.S. District Court — District of Columbia
    • June 20, 2014
    ...plan is operated,” not by implication. Davis, 871 F.2d at 1138 (emphasis added); see also Walker v. Pharin. Research & Mfrs. of Am., 569 F.Supp.2d 209, 219 (D.D.C.2008) (interpreting Davis as “declining to recognize de facto plan administrators”). Reliance therefore is not the plan administ......
  • Marcin v. Reliance Standard Life Ins. Co.
    • United States
    • U.S. District Court — District of Columbia
    • June 20, 2014
    ...plan is operated,” not by implication. Davis, 871 F.2d at 1138 (emphasis added); see also Walker v. Pharin. Research & Mfrs. of Am., 569 F.Supp.2d 209, 219 (D.D.C.2008) (interpreting Davis as “declining to recognize de facto plan administrators”). Reliance therefore is not the plan administ......
  • Olivo v. Elky
    • United States
    • U.S. District Court — District of Columbia
    • August 20, 2009
    ... ... give rise to the defense are clear from the face of the complaint." Walker v. Pharm. Research & Mfrs. of Am., 569 F.Supp.2d 209, ... 216 (D.D.C.2008) ... ...
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT